India, Aug. 30 -- Hours after the Bombay High Court accused the Maharashtra Food and Drugs Administration (FDA) of going "overboard" and acting in a "high-handed" manner, the regulator on Saturday withdrew its order cancelling the drug sale licence of Cipla Pharma and Life Sciences Ltd's carrying and forwarding (C&F) facility at Wadki in Pune.

A division bench of acting chief justice Ravindra Ghuge and justice Gautam Ankhad said the FDA had followed the wrong procedure and acted against the principles of natural justice in cancelling the licence.

The FDA told the court that it would withdraw the cancellation order with immediate effect, issue a fresh show-cause notice to Cipla and, after considering the company's response, pass a reason...